Your browser doesn't support javascript.
loading
Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL.
El Chaer, F; Holtzman, N; Binder, E; Porter, N C; Singh, Z N; Koka, M; Rapoport, A P; Emadi, A.
Afiliação
  • El Chaer F; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Holtzman N; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Binder E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Porter NC; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Singh ZN; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Koka M; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Rapoport AP; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Emadi A; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
Bone Marrow Transplant ; 52(11): 1583-1584, 2017 11.
Article em En | MEDLINE | ID: mdl-28892087
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Terapia de Salvação / Transfusão de Linfócitos / Leucemia-Linfoma Linfoblástico de Células T Precursoras Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Terapia de Salvação / Transfusão de Linfócitos / Leucemia-Linfoma Linfoblástico de Células T Precursoras Idioma: En Ano de publicação: 2017 Tipo de documento: Article